Compounds for treating metabolic disorders

TW202631693APending Publication Date: 2026-08-01INNOVENT BIOLOGICS (SUZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-10-16
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001070882_001
    Figure TWG2TA001070882_001
  • Figure TWG2TA001070882_002
    Figure TWG2TA001070882_002
  • Figure TWG2TA001070882_003
    Figure TWG2TA001070882_003
Patent Text Reader

Abstract

Compounds are provided that have activity at each of the GIP receptor, GLP-1 receptor, glucagon receptor and pcsk9. Methods also are provided for treating diseases such as diabetes mellitus, type
Need to check novelty before this filing date? Find Prior Art